Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations

SUMMARY

Biotech startup Immuneel Therapeutics has secured close to INR 100 Cr (almost $12 Mn) as a part of its extended Series A funding round from Taiba Middle East

The company’s board passed a special resolution to issue 10 equity shares and 8,164 Series A2 compulsorily convertible preference shares (CCPS) at an issue price of INR 1,22,330 each

Immuneel Therapeutics is currently valued at INR 488 Cr, as of April 30, 2024

Biotech startup Immuneel Therapeutics, cofounded by Kiran Mazumdar-Shaw, has secured close to INR 100 Cr (almost $12 Mn) as a part of its extended Series A funding round from Taiba Middle East FZ LLC.

Immuneel Therapeutics board passed a special resolution to issue 10 equity shares and 8,164 Series A2 compulsorily convertible preference shares (CCPS) at an issue price of INR 1,22,330 each to raise the fund, the company said in a filing.

The company plans to use the fresh funds for growth and expansion.

Entrackr reported the development first.

Founded in 2018 by Shaw, Kush M Parmar and Siddhartha Mukherjee, Immuneel Therapeutics offers cell and gene therapies such as chimeric antigen receptor T (CAR-T) cell therapy in India to fight cancer.

The company claims to provide affordable cancer therapy and works to offer advanced options for care, improve access and drive better patient outcomes.

Immuneel Therapeutics is currently valued at INR 488 Cr, as of April 30, 2024.

In April 2022, the Bengaluru-based startup raised close to $15 Mn in a Series A funding round led by Eight Roads Ventures, True North Fund VI LLP and F-Prime Capital, and other existing investors to scale up its operations and advance its development pipeline.

This funding adds to the list of biotech startups who are determined to expand cell therapy in the country.

Earlier this year, regenerative medicine company Pandorum Technologies raised $8 Mn from ace investor Ashish Kacholia, Everest Finance and Investment Company, among others.

Step up your startup journey with BHASKAR! From resources to networking, BHASKAR connects Indian innovators with everything they need to succeed. Join today to access a platform built for innovation, growth, and community.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.

You have reached your limit of free stories
Become An Inc42 Plus Member

Become a Startup Insider in 2024 with Inc42 Plus. Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in India’s startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
UNLOCK 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
UNLOCK 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations-Inc42 Media
Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations-Inc42 Media
You’re in Good company